Spexis achieves first CARB-X milestone for its thanatin derivatives program and receives funding of up to USD 1.9 million to initiate lead optimization

03.03.2022 - Spexis AG / Key word(s): Agreement/Financing Spexis achieves first CARB-X milestone for its thanatin derivatives program and receives funding of up to USD 1.9 million to initiate lead optimization 03-March-2022 / 07:15 CET/CEST Release of an ad hoc ... Seite 1

Related Keywords

Allschwil ,Switzerland General ,Switzerland , ,Boston University ,Outer Membrane Protein Targeting Antibiotic ,Jeff Wager ,Chief Executive Officer ,Spexis ,